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Results
Presentations
The commonest presenting features were rectal bleeding and discharge. Patients complained less commonly of a lump or of pain. Other presentations are shown in Table 1 .
Histological type and tumour stage
There were 17 (77%) patients with squamous cell carcinoma, four (18%) had basaloid tumours and one had an adenocarcinoma arising within an anal gland. The tumours were staged using the system devised by Papillon", We were only able to accurately stage 18 tumours (Table 3 ).
General practitioner diagnosis
The diagnosis at referral was noted by reviewing the general practitioner referral letters. In one patient the finding of an anal carcinoma was an incidental one during an examination for epigastric pain. In 17 patients a benign condition was diagnosed ( Table 2 ). In five patients a diagnosis of a malignant process was made, but none suggested the possibility of anal carcinoma. All were assumed to be rectal cancers. The diagnosis of anal carcinoma was correctly made on rectal examination and proctoscopic appearance when seen at their first hospital visit.
Summary
The results of treatment in 22 patients with anal carcinoma are reviewed. The overall results are disappointing with only five (28%) surviving more than 5 years. The commonest form of treatment during the study period was an abdomino-perineal excision of rectum (APER). For patients with tumours less than 2 em in diameter local excision is an acceptable alternative.
The majority (76%) of tumours were diagnosed as common benign conditions by the referring practitioners leading to a delay in initiating definitive treatment. Most tumours (81%) were greater than 2 em in diameter and therefore unsuitable for local excision.
There was a high recurrence rate (76%)amongst the group treated by APER. This along with the poor overall survival is probably due to late presentation.
Introduction
Anal carcinoma is an uncommon tumour accounting for 2-3% of large bowel tumours'P. Tumours are subdivided on the basis of whether they arise within the anal canal or from the anal margin. The latter behave like other skin cancers and consequently carry a better prognosis. The two main types of anal carcinoma are squamous cell and basaloid tumours. Rarer varieties are adenocarcinomas arising within the anal glands and the even rarer malignant melanoma.
The traditional form of treatment in this country, for all but the smallest tumours, has been a radical operation in the form of an abdomino-perineal excision of rectum (APER) with the formation of a permanent stoma", However, this method of treatment has recently been challenged with good results being claimed for radiotherapy" and chemotherapy", We have reviewed the results of surgical treatment in 22 patients over a 10-year period, and have attempted to determine any factors which might have affected their outcome.
Patients and methods
A review of patients with a diagnosis of carcinoma ofthe anus was performed for the period 1976 to 1986. Twenty-two patients were identified from pathology department records at the Royal Gwent Hospital, Newport. There was an equal incidence in men (11) and women (11). The average age was 63 years, ranging from 45 to 81 years.
The following information was recorded: mode of presentation, general practitioner diagnosis (obtained from referral letter), histological type, stage, lymph node involvement, method of treatment, timing and nature of any recurrence and final outcome. The average size of the squamous cell cancers was 3.1 cm (range 1.7-6.5 em), whereas the basaloid tumours were on average larger at 5.0 em (range 3.8-6.0 em), 
Discussion
The overall results of treatment are disappointing, only five (26%)of patients survived more than 5 years. For the group treated by APER the results were even worse with only two (15%) surviving 5 years. Only three patients had tumours which were suitable for local excision, all were less than 2 em in diameter, none had involved groin nodes and none developed a recurrence. They were tumours arising at the anal verge and thus tended to present at an earlier stage. These figures compare favourably with a series from Glasgow which reported a 5·year survival rate of 17%1. However, the results are disappointing when viewed against the Mayo clinic's claim of a 71% 5-year survival rate for APER and a 60% overall fi-year survivals. The Mayo clinic used mainly surgical means of treatment reserving radiotherapy for recurrent disease.
Treatment in this country usually takes the form of a rectal excision with formation of a permanent stoma. This form of treatment is mutilating and appears to be no more successful than regimens involving principally radiotherapy, chemotherapy or a combination of both. Squamous cell carcinoma of the anus and its metastases are radiosensitive and this prompted Papillon to treat them with radiotherapy'. Until that time the use of external beam radiation had been considered hazardous as many patients suffered radionecrosis of the perineum which can be difficult to treat and may require a colostomy to divert the faecal streams. Papillon refined the techniques and placed more emphasis on interstitial irradiation with Radium implants, lower doses of external beam radiation and significantly reduced the incidence of radiation induced complications such that he was able to claim a 65% 5-year survival" and over 80% of his patient were spared a colostomy. In the United States combinations of radiotherapy and chemotherapy are popular", The usual regimen is two cycles of 5-fluorouracil and mitomycin C combined with external beam radiation. Ifthe groin nodes are involved the radiation fields can be extended to incorporate the lymph node areas. In these treatment regimens a colostomy is only fashioned to relieve obstructive symptoms, to divert the faecal stream in cases of radionecrosis of the perineum or to control residual disease. Despite the increasing success with these therapeutic options they have remained unpopular in this country. The United Kingdom Committee for Cancer Research is conducting a multicentre trial of radiotherapy against combined treatments in patients with tumours unsuitable for local excision and hopefully this will echo the results from France and the United States.
Why should there be such diversity in results? It may be that we had a higher proportion of patients with more advanced disease. Jenson 8 has shown that an incorrect diagnosis at initial presentation leads to a delay in referralfor appropriate treatment and that this adversely affects outcome.
He showed that for squamous cell carcinoma of the anal canal a delay in diagnosis of 6 months led to a significant decrease in survival. For anal verge tumours survival was only affected after 18 months delay. In our study only 23% of patients had a correct Histological type
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Recurrence None of the patients who underwent local excision had a recurrence. Of the 17 patients who underwent APER as their primary form of treatment, 13 (76%) had a recurrence (median time to recurrence 8 months). Ten patients (77%) had a local recurrence only. Two patients (15%)had a recurrence at a distant site only and one patient had a combination of both local and distant recurrence. All patients with mesenteric lymph node metastases recurred.
Treatment
Surgery formed the mainstay of treatment: 17 patients underwent APER, three had local excision of their tumour (one also had. radiotherapy). The modes of treatment for the various histological types are shown in Table 4 . All the patients with involved groin nodes at presentation underwent block dissection.
Lymph node status
Of 20 patients in whom reliable data on the state of groin nodes was available, four (20%) had histologically proven involvement. For the 17 patients undergoing APER, four had involved mesenteric nodes. No patient with a tumour less than 2 em had involved groin nodes.
Survival
All 3 patients who underwent local excision were alive and well 5 years after their operation. The patient with inoperable disease died 4 months after diagnosis, the patient who had radiotherapy as his sole form of treatment died 29 months after diagnosis. Of the 17 patients who underwent APER, one died of cardiorespiratory failure in the immediate postoperative period; of the remaining 16 patients, two were alive and well more than 5 years after their original treatment. One patient was alive 3 years diagnosis by their general practitioner. The majority had been diagnosed as common benign conditions such as haemorrhoids. We were unable to ascertain the time between onset of symptoms and referral but it is likely that many patients were receiving treatment for their supposedly benign conditions prior to referral.
There is no internationally accepted staging system for anal cancer making comparisons between different series difficult. This problem has been addressed in a recent paper from St Mark's", However, all staging systems have as their first stage tumours less than 2 em in diameter. It is these tumours that are suitable for local excision and which carry the best prognosis. The only way to increase the percentage of patients detected at this early stage is by greater awareness amongst the public and their doctors of the significance of anorectal symptomatology.
In the Mayo series 35% of tumours were less than 2 em in diameter and therefore suitable for local excision, this would help to explain their excellent results. Only 19% of our patients had tumours in this favourable size range.
The majority of our patients (76%) undergoing APER developed a recurrence compared with only 40% treated at the Mayo clinic. It is likely that as our patients had larger tumours they also had more locally advanced disease thus explaining the higher local recurrence rate. Unfortunately due to a lack of agreement regarding the staging of tumours larger than 2 em and in particular what constitutes a T4 tumour, we are unable to make any further comparisons with other institutions. All patients with involved mesenteric lymph nodes at presentation developed a recurrence. The true incidence of lymph node metastases may well have been higher as it is well known that the rate of detection of involved nodes in pathology specimens is low amongst non-specialist colorectal units often giving a false sense of security to the surgeon.
In common with other series we found the results of a primarily surgical approach to the treatment of anal carcinoma disappointing. APER is mutilating Journal of the Royal Society of Medicine Volume 84 July 1991 397 and appears to be no more effective than radiotherapy. Undoubtedly we are seeing a higher proportion of patients with locally advanced disease. This is probably due to a delay in diagnosis of anal carcinoma by the general practitioner who most frequently diagnose common benign anal conditions. If all patients with seemingly benign anal conditions were seen promptly in hospital and any suspicious lesions biopsied, then anal carcinoma might be detected at an earlier and therefore more favourable stage in its natural history.
